193 related articles for article (PubMed ID: 23376415)
1. Stereo-selective inhibition of spinal morphine tolerance and hyperalgesia by an ultra-low dose of the alpha-2-adrenoceptor antagonist efaroxan.
Milne B; Jhamandas K; Sutak M; Grenier P; Cahill CM
Eur J Pharmacol; 2013 Feb; 702(1-3):227-34. PubMed ID: 23376415
[TBL] [Abstract][Full Text] [Related]
2. Intrathecal atipamezole augments the antinociceptive effect of morphine in rats.
Lilius TO; Rauhala PV; Kambur O; Rossi SM; Väänänen AJ; Kalso EA
Anesth Analg; 2012 Jun; 114(6):1353-8. PubMed ID: 22556211
[TBL] [Abstract][Full Text] [Related]
3. Analgesia, enhancement of spinal morphine antinociception, and inhibition of tolerance by ultra-low dose of the α2A-adrenoceptor selective antagonist BRL44408.
Milne B; Jhamandas K; Sutak M; Grenier P; Cahill CM
Eur J Pharmacol; 2014 Nov; 743():89-97. PubMed ID: 25242119
[TBL] [Abstract][Full Text] [Related]
4. Low doses of alpha 2-adrenoceptor antagonists augment spinal morphine analgesia and inhibit development of acute and chronic tolerance.
Milne B; Sutak M; Cahill CM; Jhamandas K
Br J Pharmacol; 2008 Dec; 155(8):1264-78. PubMed ID: 18806811
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of tolerance to spinal morphine antinociception by low doses of opioid receptor antagonists.
McNaull B; Trang T; Sutak M; Jhamandas K
Eur J Pharmacol; 2007 Apr; 560(2-3):132-41. PubMed ID: 17307158
[TBL] [Abstract][Full Text] [Related]
6. Intrathecal morphine and clonidine: antinociceptive tolerance and cross-tolerance and effects on blood pressure.
Solomon RE; Gebhart GF
J Pharmacol Exp Ther; 1988 May; 245(2):444-54. PubMed ID: 3367301
[TBL] [Abstract][Full Text] [Related]
7. Attenuation of tolerance to opioid-induced antinociception and protection against morphine-induced decrease of neurofilament proteins by idazoxan and other I2-imidazoline ligands.
Boronat MA; Olmos G; García-Sevilla JA
Br J Pharmacol; 1998 Sep; 125(1):175-85. PubMed ID: 9776358
[TBL] [Abstract][Full Text] [Related]
8. The antinociceptive activity of intrathecally administered amiloride and its interactions with morphine and clonidine in rats.
Ouyang H; Bai X; Huang W; Chen D; Dohi S; Zeng W
J Pain; 2012 Jan; 13(1):41-8. PubMed ID: 22154330
[TBL] [Abstract][Full Text] [Related]
9. Multiple receptors involved in peripheral alpha 2, mu, and A1 antinociception, tolerance, and withdrawal.
Aley KO; Levine JD
J Neurosci; 1997 Jan; 17(2):735-44. PubMed ID: 8987795
[TBL] [Abstract][Full Text] [Related]
10. Dissociation between morphine-induced spinal gliosis and analgesic tolerance by ultra-low-dose α2-adrenergic and cannabinoid CB1-receptor antagonists.
Grenier P; Wiercigroch D; Olmstead MC; Cahill CM
Behav Pharmacol; 2018 Apr; 29(2 and 3-Spec Issue):241-254. PubMed ID: 29481424
[TBL] [Abstract][Full Text] [Related]
11. Low dose alpha-2 antagonist paradoxically enhances rat norepinephrine and clonidine analgesia.
Milne B; Sutak M; Cahill CM; Jhamandas K
Anesth Analg; 2011 Jun; 112(6):1500-3. PubMed ID: 21543786
[TBL] [Abstract][Full Text] [Related]
12. Antinociceptive interactions between alpha 2-adrenergic and opiate agonists at the spinal level in rodents.
Ossipov MH; Suarez LJ; Spaulding TC
Anesth Analg; 1989 Mar; 68(3):194-200. PubMed ID: 2537587
[TBL] [Abstract][Full Text] [Related]
13. Moxonidine, a selective alpha2-adrenergic and imidazoline receptor agonist, produces spinal antinociception in mice.
Fairbanks CA; Wilcox GL
J Pharmacol Exp Ther; 1999 Jul; 290(1):403-12. PubMed ID: 10381806
[TBL] [Abstract][Full Text] [Related]
14. Tramadol antinociception is potentiated by clonidine through α₂-adrenergic and I₂-imidazoline but not by endothelin ET(A) receptors in mice.
Andurkar SV; Gendler L; Gulati A
Eur J Pharmacol; 2012 May; 683(1-3):109-15. PubMed ID: 22449379
[TBL] [Abstract][Full Text] [Related]
15. The involvement of peripheral alpha 2-adrenoceptors in the antihyperalgesic effect of oxcarbazepine in a rat model of inflammatory pain.
Tomić MA; Vucković SM; Stepanović-Petrović RM; Ugresić ND; Paranos SLj; Prostran MS; Bosković B
Anesth Analg; 2007 Nov; 105(5):1474-81, table of contents. PubMed ID: 17959985
[TBL] [Abstract][Full Text] [Related]
16. Central administration of selective melanocortin 4 receptor antagonist HS014 prevents morphine tolerance and withdrawal hyperalgesia.
Kalange AS; Kokare DM; Singru PS; Upadhya MA; Chopde CT; Subhedar NK
Brain Res; 2007 Nov; 1181():10-20. PubMed ID: 17915196
[TBL] [Abstract][Full Text] [Related]
17. Ultra-low dose naloxone restores the antinociceptive effect of morphine in pertussis toxin-treated rats by reversing the coupling of mu-opioid receptors from Gs-protein to coupling to Gi-protein.
Tsai RY; Tai YH; Tzeng JI; Cherng CH; Yeh CC; Wong CS
Neuroscience; 2009 Dec; 164(2):435-43. PubMed ID: 19682558
[TBL] [Abstract][Full Text] [Related]
18. Ketorolac prevents recurrent withdrawal induced hyperalgesia but does not inhibit tolerance to spinal morphine in the rat.
Dunbar SA; Karamian I; Zhang J
Eur J Pain; 2007 Jan; 11(1):1-6. PubMed ID: 16448827
[TBL] [Abstract][Full Text] [Related]
19. Influence of low doses of naltrexone on morphine antinociception and morphine tolerance in male and female rats of four strains.
Terner JM; Barrett AC; Lomas LM; Negus SS; Picker MJ
Pain; 2006 May; 122(1-2):90-101. PubMed ID: 16527399
[TBL] [Abstract][Full Text] [Related]
20. Different roles of alpha 2-adrenoceptors of the medulla versus the spinal cord in modulation of mustard oil-induced central hyperalgesia in rats.
Mansikka H; Idänpään-Heikkilä JJ; Pertovaara A
Eur J Pharmacol; 1996 Feb; 297(1-2):19-26. PubMed ID: 8851161
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]